X
Log In
Username or E-mail:
Password:
EULA
Log In
Forgot Password
Sign Up
Sign Up
Username:
E-mail:
Password:
EULA
Sign Up
Forgot Password
Already a Member
Username or E-mail
Send Forgot Mail
Back to Login
EULA
X
Share This!
Sign Up
Log In
Logout
X
English Türkçe

ESPR

Closed

Esperion Therapeutics Inc

1.
0 (0.00%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 0.9844
Day's Range: 0.949 - 1.04
Send
When Written:
 
1.59
Esperion Therapeutics Inc. is a publicly-traded biopharmaceutical company based in Ann Arbor, Michigan, USA. The company specializes in the development of novel therapies for the treatment of cardiovascular and metabolic diseases. Esperion's lead product candidate is bempedoic acid, a small molecule inhibitor of ATP citrate lyase, which is currently in Phase 3 clinical trials for the treatment of hyperlipidemia and atherosclerosis. The company was founded in 2008 and went public in 2013. Esperion has partnerships with several pharmaceutical companies, including Daiichi Sankyo, Zydus Cadila, and Otsuka Pharmaceutical Co. Ltd.

Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
Contact with us

Mail:
Message:
Cancel
Send
IP Adresiniz:216.73.216.15
X